As of Mar 31
| -2.53 / -2.69%|
The 13 analysts offering 12-month price forecasts for Incyte Corp have a median target of 92.00, with a high estimate of 103.00 and a low estimate of 80.00. The median estimate represents a +0.37% increase from the last price of 91.66.
The current consensus among 15 polled investment analysts is to Buy stock in Incyte Corp. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.